Aarey Drugs & Pharmaceuticals Ltd.
| BSE: 524412 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE198H01019 |
| BSE 15:19 | 15 Jun | 33.80 |
-0.05 (-0.15%) |
OPEN
34.40 |
HIGH
34.90 |
LOW
33.35 |
| NSE 05:30 | 01 Jan | Aarey Drugs & Pharmaceuticals Ltd |
| OPEN | 34.40 |
| PREVIOUS CLOSE | 33.85 |
| VOLUME | 155058 |
| 52-Week high | 42.00 |
| 52-Week low | 16.15 |
| P/E | 13.41 |
| Mkt Cap.(Rs cr) | 79 |
| Buy Price | 33.50 |
| Buy Qty | 614.00 |
| Sell Price | 33.70 |
| Sell Qty | 500.00 |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 673.35 | -3.90 | -0.58 | 3211.14 |
| Dr Reddy's Labs | 5408.50 | -51.05 | -0.94 | 2937.70 |
| Cipla | 968.50 | -7.70 | -0.79 | 2318.17 |
| Aurobindo Pharma | 992.70 | -1.65 | -0.17 | 1872.74 |
| Cadila Health. | 646.40 | -8.80 | -1.34 | 1412.90 |
| Divi's Lab. | 4311.25 | -75.80 | -1.73 | 1372.71 |
| Glenmark Pharma. | 640.30 | -3.35 | -0.52 | 1354.55 |
| Alkem Lab | 3183.95 | -49.10 | -1.52 | 1264.42 |
| Alembic Pharma | 998.20 | 3.65 | 0.37 | 969.40 |
| Torrent Pharma. | 2928.00 | -51.65 | -1.73 | 938.51 |
| Gland Pharma | 3142.00 | -15.55 | -0.49 | 772.86 |
| Lupin | 1187.00 | -5.60 | -0.47 | 727.55 |
| Ipca Labs. | 2064.35 | -30.15 | -1.44 | 652.46 |
| Abbott India | 16441.95 | 160.45 | 0.99 | 592.93 |
| Fortis Health. | 232.50 | -1.70 | -0.73 | 513.33 |
| Pfizer | 5492.05 | -65.65 | -1.18 | 509.13 |
| Sanofi India | 7749.20 | -65.15 | -0.83 | 477.60 |
| Natco Pharma | 1108.15 | 2.30 | 0.21 | 474.50 |
| Apollo Hospitals | 3297.80 | -53.65 | -1.60 | 470.30 |
| Granules India | 328.35 | -0.75 | -0.23 | 444.07 |
Quick Links for Aarey Drugs & Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
